Search Results - "Klippel, John H"

Refine Results
  1. 1

    Measuring quality in arthritis care: Methods for developing the Arthritis Foundation's quality indicator set by MacLean, Catherine H., Saag, Kenneth G., Solomon, Daniel H., Morton, Sally C., Sampsel, Sarah, Klippel, John H.

    Published in Arthritis and rheumatism (15-04-2004)
    “…Objective To develop a comprehensive set of explicit process measures to assess the quality of health care for osteoarthritis, rheumatoid arthritis, and…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset by Goldbach-Mansky, R, Lee, J, McCoy, A, Hoxworth, J, Yarboro, C, Smolen, J S, Steiner, G, Rosen, A, Zhang, C, Ménard, H A, Zhou, Z J, Palosuo, T, Van Venrooij, W J, Wilder, R L, Klippel, J H, Schumacher, Jr, H R, El-Gabalawy, H S

    Published in Arthritis research (01-01-2000)
    “…STATEMENT OF FINDINGS: An inception cohort of 238 patients having peripheral joint synovitis of less than 12 months duration was evaluated clinically and…”
    Get full text
    Journal Article
  5. 5

    Biologic Therapy for Rheumatoid Arthritis by Klippel, John H

    Published in The New England journal of medicine (30-11-2000)
    “…This year marks the 50th anniversary of the awarding of the Nobel Prize in Physiology and Medicine to Kendall, Hench, and Reichstein for the isolation and…”
    Get full text
    Journal Article
  6. 6

    Systemic Lupus Erythematosus: Presence in Human Serum of an Unusual Acid-Labile Leukocyte Interferon by Preble, Olivia T., Black, Roberta J., Friedman, Robert M., Klippel, John H., Vilcek, Jan

    “…A previously undescribed species of human leukocyte, or alpha, interferon is present in the serum of many patients with systemic lupus erythematosus. It was…”
    Get full text
    Journal Article
  7. 7

    Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus by Leitman, Susan F., Tisdale, John F., Bolan, Charles D., Popovsky, Mark A., Klippel, John H., Balow, James E., Boumpas, Dimitrios T., Illei, Gabor G.

    Published in Transfusion (Philadelphia, Pa.) (01-12-2003)
    “…BACKGROUND: Fludarabine, a purine antimetabolite with potent immunosuppressive properties, has previously been associated with the development of…”
    Get full text
    Journal Article
  8. 8

    Effect of treatment on the evolution of renal abnormalities in lupus nephritis by Balow, J E, Austin, 3rd, H A, Muenz, L R, Joyce, K M, Antonovych, T T, Klippel, J H, Steinberg, A D, Plotz, P H, Decker, J L

    Published in The New England journal of medicine (23-08-1984)
    “…We retrospectively studied the evolution of histopathologic features in successive renal biopsies in patients with lupus nephritis, to evaluate the effects of…”
    Get more information
    Journal Article
  9. 9

    Second-Line Drug Therapy for Rheumatoid Arthritis by Cash, Joseph M, Klippel, John H

    Published in The New England journal of medicine (12-05-1994)
    “…Three major classes of drugs are used in the treatment of patients with rheumatoid arthritis: nonsteroidal antiinflammatory drugs, corticosteroids, and drugs…”
    Get full text
    Journal Article
  10. 10

    End-stage renal disease and systemic lupus erythematosus by Mojcik, C F, Klippel, J H

    Published in The American journal of medicine (01-07-1996)
    “…To provide an overview of the course of systemic lupus erythematosus (SLE) following the onset of end-stage lupus nephropathy, regarding clinical and…”
    Get more information
    Journal Article
  11. 11

    Systemic Lupus Erythematosus: Treatment-Related Complications Superimposed on Chronic Disease by Klippel, John H

    “…SELECTED CASEA 40-YEAR-OLD black woman with systemic lupus erythematosus (SLE) has been followed up in the arthritis clinic at the National Institutes of…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Modified oral ondansetron regimen for cyclophosphamide-induced emesis in lupus nephritis by Yarboro, C H, Wesley, R, Amantea, M A, Klippel, J H, Pucino, F

    Published in The Annals of pharmacotherapy (01-07-1996)
    “…To evaluate the antiemetic efficacy of a modified regimen of oral ondansetron and dexamethasone in patients with lupus nephritis undergoing treatment with…”
    Get more information
    Journal Article
  15. 15

    8 Indications for, and use of, cytotoxic agents in SLE by Klippel, John H.

    Published in Baillière's clinical rheumatology (01-08-1998)
    “…Over the past decade, cytotoxic drugs have come to assume an increasingly important role in the management of systemic lupus erythematosus. Intravenous…”
    Get full text
    Journal Article
  16. 16

    Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis : A randomized, controlled trial by GOURLEY, M. F, AUSTIN, H. A, SCOTT, D, YARBORO, C. H, VAUGHAN, E. M, MUIR, J, BOUMPAS, D. T, KLIPPEL, J. H, BALOW, J. E, STEINBERG, A. D

    Published in Annals of internal medicine (01-10-1996)
    “…Uncertainty exists about the efficacy and toxicity of bolus therapy with methylprednisolone or of the combination of methylprednisolone and cyclophosphamide in…”
    Get full text
    Journal Article
  17. 17
  18. 18

    B-lymphocyte alloantigens associated with systemic lupus erythematosus by Reinertsen, J L, Klippel, J H, Johnson, A H, Steinberg, A D, Decker, J L, Mann, D L

    Published in The New England journal of medicine (07-09-1978)
    “…We examined B-lymphocyte alloantigens in 41 patients with systemic lupus erythematosus and 184 controls, using a panel of 47 pregnancy serums, and compared…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease by Boumpas, D T, Austin, 3rd, H A, Fessler, B J, Balow, J E, Klippel, J H, Lockshin, M D

    Published in Annals of internal medicine (15-06-1995)
    “…To review advances and controversies in the diagnosis and management of systemic lupus erythematosus with visceral involvement (renal, neuropsychiatric,…”
    Get full text
    Journal Article